Chapel Hill, NC, United States of America

Mark H Schoenfisch

USPTO Granted Patents = 32 (Patent Applications = 11)

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 2.8

ph-index = 9

Forward Citations = 212(Granted Patents)

Company Filing History:

30 out of 1,271

The University of North Carolina at Chapel Hill

Kwangwoon University Industry-Academic Collaboration Foundation

patents

4. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460050 - Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto (2025-11-04),

2. 12257314 - Extended nitric oxide-releasing polymers via functionalized mesoporous silica nanoparticles (2025-03-25),

3. 12173090 - Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto (2024-12-24),

4. 11723914 - Nitric oxide-releasing polyaminoglycosides as biodegradable antibacterial scaffolds and methods pertaining thereto (2023-08-15),

5. 11697693 - Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto (2023-07-11),

6. 11691995 - Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications (2023-07-04),

7. 11672818 - Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto (2023-06-13),

8. 11421044 - Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto (2022-08-23),

9. 11420986 - Functionalized mesoporous silica via an aminosilane surfactant ion exchange reaction: controlled scaffold design and nitric oxide release (2022-08-23),

10. 11324773 - Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus (2022-05-10),

11. 11186681 - S-Nitrosothiol-mediated hyperbranched polyesters (2021-11-30),

12. 11124476 - Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures (2021-09-21),

13. 11072668 - Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto (2021-07-27),

14. 11026965 - Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto (2021-06-08),

15. 10759877 - Water soluble nitric oxide-releasing polyglucosamines and uses thereof (2020-09-01),

Title: The Innovative Journey of Mark H. Schoenfisch

Introduction: Mark H. Schoenfisch, a pioneering inventor based in Chapel Hill, NC, has made significant contributions to the field of innovations and inventions with his groundbreaking work.

Latest Patents: Mark H. Schoenfisch holds several patents in the areas of biomedical engineering and nanotechnology, focusing on developing novel materials for medical applications.

Career Highlights: With a distinguished career spanning over two decades, Mark H. Schoenfisch has been at the forefront of cutting-edge research, particularly in the development of advanced healthcare technologies.

Collaborations: Throughout his career, Mark H. Schoenfisch has collaborated with leading researchers, scientists, and medical professionals to bring his innovative ideas to life and make a lasting impact in the industry.

Conclusion: Mark H. Schoenfisch's relentless pursuit of innovation and his passion for creating solutions that improve lives have solidified his reputation as a visionary inventor in the field of biomedical engineering.

This text is generated by artificial intelligence and may not be accurate.